Quantcast

Latest Lipitor Stories

Cholesterol Drugs Equally Effective In Reducing Plaque
2011-11-15 13:32:45

A new study has found that Pfizer Inc.'s Lipitor and AstraZeneca's Crestor cholesterol drugs are both equally effective in treating coronary artery disease. Crestor caused a bigger drop in LDL cholesterol than Lipitor, but they both tied when it came to reducing plaque.  LDL cholesterol is the bad kind that can cause build-up of plaque inside the arteries. "The good thing is that these are both effective drugs," Stephen Nicholls, clinical director of the Cleveland Clinic Center for...

2011-10-27 06:25:44

(Ivanhoe Newswire) -- Women with lupus are 50 times more likely to have a heart attack; and all lupus patients are eight times more likely to develop premature coronary heart disease than the general population. Statins, a class of drug used to lower cholesterol, have been shown to reduce arthrosclerosis progression in adults, but have not been investigated in a pediatric lupus population. Atherosclerosis is a build-up of plaque in the arterial wall which can lead to heart attack and...

6fc0a6e0493b5d09890cfcaf2104d165
2011-08-04 10:34:48

US regulators will be considering a plan from pharmaceutical giant Pfizer to introduce an over-the-counter version of its top-selling heart drug Lipitor. Selling the popular anti-cholesterol drug without a prescription could help Pfizer's bottom line as the company faces a "patent cliff" that threatens to erode profits during the next few years, according to the Wall Street Journal. Lipitor will soon lose patent protection and face competition from cheaper generic versions of its popular...

2011-06-28 06:01:00

LONDON, June 28, 2011 /PRNewswire/ -- Rheumatoid arthritis treatment Humira will assume Lipitor's crown as the world's biggest selling drug, while Pfizer will cling on to its ranking as the biggest seller of prescription medicines through to 2016, according to the World Preview 2016 (second edition) report published today by EvaluatePharma, the premier provider of pharma and biotech analysis. Lipitor's patent expiry this year precipitates the steepest decline in the...

7d332a7f69a090139fee4ee58f64653b1
2011-03-29 06:11:54

More evidence has linked the cholesterol-lowering drug Lipitor to an increased risk of type 2 diabetes, especially in patients who have multiple diabetes risk factors, according to a study published on Monday. A number of previous studies have linked Lipitor and other cholesterol medications (statins) to a small increase in the risk of diabetes. And the new study, based on data from three large clinical trials, further supports that connection. But the new study also suggests the risk might...

2011-02-02 09:12:00

LONDON, February 2, 2011 /PRNewswire/ -- Thirteen US blockbusters will lose patent protection over the next two years, data from EvaluatePharma show, highlighting the challenges facing the pharmaceutical industry in the coming years. With the reporting season in full swing it is no wonder that several big pharmaceutical company chief executives have warned of tough times ahead. - Drugs worth $15.3bn face generic competition this year - "At risk" sales to more than double to...

2010-11-18 09:00:00

BURLINGTON, Mass., Nov. 18, 2010 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that in the treatment of dyslipidemia, surveyed cardiologists and primary care physicians (PCPs) now perceive AstraZeneca's Crestor's ability to reduce mortality comparable to Pfizer's Lipitor. This finding has changed from Decision Resources' 2009 analysis in which surveyed cardiologists viewed Lipitor as significantly...

2010-11-02 06:00:00

NEW YORK, Nov. 2, 2010 /PRNewswire-FirstCall/ -- Third-Quarter 2010 Revenues of $16.2 Billion Third-Quarter 2010 Adjusted Diluted EPS((1)) of $0.54; Reported Diluted EPS((2)) of $0.11 Tightens Ranges for 2010 Financial Guidance Components, Increases Range for Adjusted Diluted EPS((1)) and Reduces Range for Reported Diluted EPS((2)); Reaffirms 2012 Financial Targets Advances Strategic Priorities with Agreement to Acquire King Pharmaceuticals, Inc., Acquisition of FoldRx, Alliance with...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related